December 2, 2016 | 11 am to 12 pm EST

Sponsored by



Webinar Description:

This webinar will highlight the use of a Simoa custom assay and the commercial tau assay for different applications in mouse and human studies in both cerebrospinal fluid (mouse) and blood (humans). These studies demonstrate the novel biomarker applications by Simoa.

Learning Objectives:

  • Technical aspects of Simoa
  • Novel biomarker assay development
  • Applications in pre-clinical and clinical studies 


Michelle M MielkeDr. Michelle M. Mielke, PhD

Professor of Epidemiology and Neurology

The Mayo Clinic, Rochester, MN

Dr. Michelle M. Mielke, PhD is a Professor of Epidemiology and Neurology at the mayo Clinic, Rochester, MN. Her main areas of research interest are understanding the epidemiology of neurological disorders and identifying fluid biomarkers for CNS disorders.

Stephan KaesarDr. Stephan Kaeser, PhD

HIH Hertie Institute for Clinical Brain Research

Department of Cellular Neurology, University of Tuebingen, Tuebingen, Germany, DZNE German Center for Neurodegenerative Diseases, Tuebingen, Germany

Main research interest: Fluid biomarkers in translational research of neurodegenerative diseases

Andreas Jeromin, PhD. CMO (Consulting) Quanterix